Epinephrine Market - Top Companies and Manufacturers

  • Report ID: 4413
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Epinephrine Landscape

    • Teva Pharmaceuticals Industries Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Amneal Pharmaceuticals, Inc.
    • Adamis Pharmaceuticals Corporation
    • Antares Pharma, Inc.
    • Pfizer Inc.
    • kaleo, Inc.
    • ALK-Abelló A/S
    • Bausch Health Companies Inc.
    • Viatris Inc.
    • Abbott Laboratories 

Browse Key Market Insights with Data Illustration:

In the News

  • Pfizer Inc. announced that it is in coordination with FDA to extend the expiration dates of certain lots of EpiPen 0.3 mg Auto-Injectors after reviewing the stability data. Pfizer works to stabilize the supply of these particular lots of products so that patients feel confident using them.

  • Teva Pharmaceuticals Industries Ltd. announced the accessibility of the FDA-approved generic version of EpiPen Jr 1 (epinephrine injection, USP) Auto-Injector, 0.15 mg, in the U.S. Currently, the product is available in pharmacies nationwide.


Author Credits:  Radhika Pawar


  • Report ID: 4413
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of epinephrine is evaluated at USD 1.37 billion.

The epinephrine market size was over USD 1.25 billion in 2024 and is likely to exceed USD 5.77 billion by the end of 2037, witnessing over 12.3% CAGR during the forecast period i.e., between 2025-2037. Upsurge in chronic respiratory disorders, growing occurrence of several types of allergic reactions, escalation in cardiac arrests will drive the market growth.

North America is predicted to account for largest industry share by 2037, attributed to escalating count of patients suffering from respiratory diseases such as asthma, coupled with rapidly expanding population in the region.

The major players in the market include Teva Pharmaceuticals Industries Ltd., Amneal Pharmaceuticals, Inc., Adamis Pharmaceuticals Corporation, Antares Pharma, Inc., Pfizer Inc., kaleo, Inc., ALK-Abelló A/S, Bausch Health Companies Inc., Viatris Inc., Abbott Laboratories.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample